Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.09 earnings per share for the quarter, hitting the consensus estimate of $0.09, Zacks reports. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%.
Coloplast A/S Price Performance
Shares of OTCMKTS:CLPBY opened at $6.75 on Tuesday. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $9.70. The firm has a market capitalization of $15.21 billion, a P/E ratio of 35.53, a P/E/G ratio of 2.56 and a beta of 0.21. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The company’s fifty day moving average price is $6.82 and its 200 day moving average price is $6.81.
About Coloplast A/S
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
See Also
- Five stocks we like better than Coloplast A/S
- Check Point’s Turnaround Could Be Closer Than Investors Think
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
